For research use only
| Cat No. | ABC-SC2070 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Cell Type: iPSC; Primary Tissue: PBMC Reprogramming Method: Episomal Plasmid; Disease: Control.
HighQC™ Human IPSC From PBMC-Control is a human induced pluripotent stem cell line derived from peripheral blood mononuclear cells (PBMCs) obtained from a healthy donor. The reprogramming was achieved using non-integrating episomal plasmids. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent, typical compact, and clone-like growth with a high nucleus-to-cytoplasm ratio. These PBMC-derived control iPSCs act as standard controls for developmental and pathological mechanism research. These cells demonstrate the fundamental capacity for trilineage differentiation, enabling the generation of cell types representing the ectoderm, mesoderm, and endoderm germ layers under directed conditions. They express the core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From PBMC-Control, HighQC™ hiPSC PBMC Control, hiPSC-PBMC-Control, HighQC™ Human Induced Pluripotent Stem Cells From Peripheral Blood Mononuclear Cells-Control |
| Species | Human |
| Cat.No | ABC-SC2070 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human IPSC From PBMC-Control serves as a standard normal control for in vitro developmental biology and disease modeling research. Its core pluripotent capacity enables directed differentiation into various lineages such as neurons, cardiomyocytes, and hepatocytes. This cell line provides an essential baseline for comparative studies against disease-specific models, supports gene function and pathway validation, and can further advance stem cell research while unlocking promising potential for applications in regenerative medicine.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).